Literature DB >> 3067575

Interstitial and terminal deletions of the long arm of chromosome 4: further delineation of phenotypes.

A E Lin1, K L Garver, G Diggans, M Clemens, S L Wenger, M W Steele, M C Jones, J Israel.   

Abstract

We reviewed 45 patients with a deletion of the long arm of chromosome 4. Forty-one were previous reports (25 terminal deletions and 16 interstitial deletions) and 4 are new cases with terminal deletions. Of the 29 patients with terminal deletions, 18 with deletion at 4q31 and 4 at 4q32----qter had an identifiable phenotype consisting of abnormal skull shape, hypertelorism, cleft palate, apparently low-set abnormal pinnae, short nose with abnormal bridge, virtually pathognomonic pointed fifth finger and nail, congenital heart and genitourinary defects, moderate-severe mental retardation, poor postnatal growth, and hypotonia. Six patients with a deletion at 4q33 and one patient with deletion 4q34 were less severely affected. In general, patients with various interstitial deletions proximal to 4q31 had a phenotype that was less specific, although mental retardation and minor craniofacial anomalies were also present. There were 3 patients with piebaldism and one with Rieger syndrome. We conclude that terminal deletion of chromosome 4q (4q31----qter) appears to produce a distinctive malformation (MCA/MR) syndrome in which the phenotype correlates with the amount of chromosome material missing and which differs from the more variable phenotype associated with interstitial deletions of 4q.

Entities:  

Mesh:

Year:  1988        PMID: 3067575     DOI: 10.1002/ajmg.1320310308

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  23 in total

1.  Genomic imbalances in mental retardation.

Authors:  M Kriek; S J White; M C Bouma; H G Dauwerse; K B M Hansson; J V Nijhuis; B Bakker; G-J B van Ommen; J T den Dunnen; M H Breuning
Journal:  J Med Genet       Date:  2004-04       Impact factor: 6.318

2.  4q34.1-q35.2 deletion in a boy with phenotype resembling 22q11.2 deletion syndrome.

Authors:  Goran Cuturilo; Björn Menten; Aleksandar Krstic; Danijela Drakulic; Ida Jovanovic; Vojislav Parezanovic; Milena Stevanovic
Journal:  Eur J Pediatr       Date:  2011-07-22       Impact factor: 3.183

3.  Interstitial deletion of the distal long arm of chromosome 4.

Authors:  P Sarda; G Lefort; J P Fryns; C Humeau; D Rieu
Journal:  J Med Genet       Date:  1992-04       Impact factor: 6.318

4.  Phenotypical manifestations of partial trisomy 9 and monosomy 4 in two siblings.

Authors:  Matthew Vanlandingham; Tuan V Nguyen; Omar A Abdul-Rahman; Andrew Parent; Jun Zhang
Journal:  Neurol Sci       Date:  2008-11-27       Impact factor: 3.307

5.  Interstitial deletion of chromosome 4, del(4)(q12q21.1), in a child with multiple congenital abnormalities.

Authors:  M A Curtis; O W Quarrell; A M Cobon; M Cummins
Journal:  J Med Genet       Date:  1990-01       Impact factor: 6.318

Review 6.  Toward the complete genomic map and molecular pathology of human chromosome 4.

Authors:  O Riess; B Winkelmann; J T Epplen
Journal:  Hum Genet       Date:  1994-07       Impact factor: 4.132

7.  Interstitial deletion, del(4)(q33q35.1), in a mother and two children.

Authors:  M A Curtis; R A Smith; J Sibert; H E Hughes
Journal:  J Med Genet       Date:  1989-10       Impact factor: 6.318

8.  Detection of chromosomal aberrations by a whole-genome microsatellite screen.

Authors:  M J Rosenberg; D Vaske; C E Killoran; Y Ning; D Wargowski; L Hudgins; C J Tifft; J Meck; J K Blancato; K Rosenbaum; R M Pauli; J Weber; L G Biesecker
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

Review 9.  Clinical and genomic characterization of distal duplications and deletions of chromosome 4q: study of two cases and review of the literature.

Authors:  Michael R Rossi; Miriam S DiMaio; Bixia Xiang; Kangmo Lu; Hande Kaymakcalan; Margretta Seashore; Maurice J Mahoney; Peining Li
Journal:  Am J Med Genet A       Date:  2009-12       Impact factor: 2.802

10.  The PDGF-C regulatory region SNP rs28999109 decreases promoter transcriptional activity and is associated with CL/P.

Authors:  Sun J Choi; Mary L Marazita; P Suzanne Hart; Pawel P Sulima; L Leigh Field; Toby Goldstein McHenry; Manika Govil; Margaret E Cooper; Ariadne Letra; Renato Menezes; Somnya Narayanan; Maria Adela Mansilla; José M Granjeiro; Alexandre R Vieira; Andrew C Lidral; Jeffrey C Murray; Thomas C Hart
Journal:  Eur J Hum Genet       Date:  2008-12-17       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.